Skip to main content
75°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Scholar Rock Holding Corporation - Common Stock
(NQ:
SRRK
)
37.44
-0.68 (-1.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Scholar Rock Holding Corporation - Common Stock
< Previous
1
2
3
4
5
Next >
Scholar Rock to Participate in Upcoming Investor Conferences
October 31, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting
October 31, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering
October 22, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 18, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants
October 08, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
October 07, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)
October 07, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 13, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity
September 10, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer
September 04, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock to Participate in Upcoming Investor Conferences
August 29, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 16, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress
August 08, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
July 23, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 12, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal
June 24, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting
June 03, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
May 22, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock to Participate in Upcoming Investor Conferences
May 20, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock to Host Investor Day on May 22, 2024
May 14, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
May 07, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 12, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
March 19, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2024
From
Scholar Rock, Inc.
Via
Business Wire
Scholar Rock to Participate in Upcoming Investor Conferences
February 28, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 16, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
February 15, 2024
From
Scholar Rock
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.